Vimarsana
Biggest News Aggregation in the World

Page 7 - Ben Brahim News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ben Brahim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ben Brahim Today - Breaking & Trending Today

Transgene and NEC Announce Positive Preliminary Data from Phase I Studies of TG4050, a Novel Individualized Neoantigen Cancer Vaccine - Vimarsana News

Transgene and NEC Announce Positive Preliminary Data from Phase I Studies of TG4050, a Novel Individualized Neoantigen Cancer Vaccine

Positive initial data generated in the first six patients treated with TG4050 demonstrate the strong potential of this individualized immunotherapy in ovarian cancer and head and neck cancer- TG4050 induced

'Tina': New documentary explores successes and struggles of global superstar - Vimarsana News

'Tina': New documentary explores successes and struggles of global superstar

'Tina': New documentary explores successes and struggles of global superstar Issued on: 01/06/2021 - 16:50 ENCORE! © Universal Pictures 14 min A new documentary shines a spotlight on Tina Turner's ascent to stardom, as well as her abusive relationship with Ike Turner. It mixes intimate interviews with the now 81-year-old singer-songwriter and those close to her, as well as rare archival footage. FRANCE 24's Jennifer Ben Brahim spoke to the directors of the documentary to find out more. Advertising We also take a look a...

Transgene and BioInvent Receive IND Approval from the U.S. FDA for BT-001, a Novel Oncolytic Virus for the Treatment of Solid Tumors - Vimarsana News

Transgene and BioInvent Receive IND Approval from the U.S. FDA for BT-001, a Novel Oncolytic Virus for the Treatment of Solid Tumors

Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and BioInvent International AB ("BioInvent")

BioInvent and Transgene receive IND approval from the U.S. FDA for BT-001, a novel oncolytic virus for the treatment of solid tumors - Vimarsana News

BioInvent and Transgene receive IND approval from the U.S. FDA for BT-001, a novel oncolytic virus for the treatment of solid tumors

/PRNewswire/ -- BioInvent International AB ("BioInvent") (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of novel and...

Transgene: Combined General Meeting of May 26, 2021 - Vimarsana News

Transgene: Combined General Meeting of May 26, 2021

Regulatory News: The Combined Ordinary and Extraordinary General Meeting of Transgene's (Paris:TNG) shareholders was held today (May 26, 2021) at 10:00 a.m. at the Company's headquarters (400 boulevard